Clinical Trials Logo

Insomnia Due to Anxiety and Fear clinical trials

View clinical trials related to Insomnia Due to Anxiety and Fear.

Filter by:
  • None
  • Page 1

NCT ID: NCT05280561 Completed - Clinical trials for Insomnia Due to Anxiety and Fear

Stress-induced Sleep Deficits and a Complementary Therapy

Sleep-Aid
Start date: July 25, 2021
Phase: N/A
Study type: Interventional

The COVID-19 pandemic and social isolation order induced stress/anxiety as well as cellphone dependence. As a result, sleep disruption and mental distress became major health concerns. Gamma-aminobutyric acid type-A receptor (GABAAR) is one of the key players in modulating sleep. Dihydromyricetin (DHM), an herbal compound, plays a role in GABAAR modulation and mitigating anxiety. The investigators' partner in China obtained 288 participants who completed the online survey to gain insight into how stress/anxiety and time spent on cellphones affected sleep and mood. The participants were then enrolled in a randomized placebo-controlled double-blind study to assess the effects of DHM on sleep and improvement on stress/anxiety and cellphone using time.

NCT ID: NCT05253417 Completed - Insomnia Clinical Trials

The CANabidiol Use for RElief of Short Term Insomnia

CANREST
Start date: May 1, 2022
Phase: Phase 2
Study type: Interventional

This study aims to investigate the effect of 50 mg and 100 mg per day oral CBD product versus a placebo over 8 weeks on insomnia severity in adults aged 18-65 years old with insomnia symptoms.

NCT ID: NCT05152095 Recruiting - Clinical trials for Insomnia Due to Anxiety and Fear

Therapeutic Effect of Self-administered Auricular Acupressure on Insomnia Induced by Anxiety

Start date: November 13, 2021
Phase: N/A
Study type: Interventional

This is a sham-controlled randomized trial to identify the effectiveness of treating insomnia induced by anxiety with self-administered auricular acupressure in Malaysia.

NCT ID: NCT04571593 Completed - Clinical trials for Insomnia Due to Anxiety and Fear

Remote Yoga Nidra for Anxiety and Sleep

Start date: April 15, 2020
Phase: N/A
Study type: Interventional

The goal of this application is to collect survey data indicating the effects of a digital Yoga Nidra practice on anxiety and sleep during COVID-19. We will explore effects on momentary anxiousness, as well as on sleep. Participants will be consented through REDCap during the Yoga Nidra class, then asked to complete an intake form, a sleep questionnaire (composed of questions from the Post Sleep Questionnaire (PSQ)) and a pre/post State Trait Anxiety (STAI) Index, surrounding the practice. Participants will receive an email the next morning, inquiring about their sleep (~2 min survey), and again the following week, the morning of the Yoga Nidra class, in order to remind them about the weekly class offering and also to collect sleep data for a night that did not include pre-bed Yoga Nidra. We will additionally report feasibility measures including enrollment, retention, qualitative feedback, and challenges of using the digital platform. Using this data, we will gain valuable feasibility data for implementation of this type of mind-body practice using digital platforms. We will also gain important data on the effects of this practice on anxiety and sleep.